Successful cytokine treatment of aplastic anemia following living related orthotopic liver transplantation for non-A, non-B, non-C hepatitis

Clinical Transplantation

Volumn 13, Issue 1 I, 1999, Pages 68-71

  Sato, Sumihiko ^a   Fuchinoue, Shohei ^b   Abe, Masahiro ^b   Kitajima, Kumiko ^b   Tojimbara, Tamotsu ^b   Nakajima, Ichiro ^b   Agishi, Tetsuzo ^b   Shiraga, Hiroshi ^b   Ito, Katsumi ^b   Takasaki, Ken ^b   Hashimoto, Etsuko ^b   Hayashi, Naoaki ^b   Tanaka, Koichi ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Cyclosporine; Cytokine therapy; Fulminant hepatitis; G CSF; Hepatitis associated aplastic anemia; Liver transplantation; M CSF; Methyloprednisolon; rhEPO

Indexed keywords

COLONY STIMULATING FACTOR 1; CYCLOSPORIN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; RECOMBINANT ERYTHROPOIETIN;

APLASTIC ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; HEPATITIS NON A NON B; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; ORAL DRUG ADMINISTRATION; PANCYTOPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0033056335     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.130112.x     Document Type: Article

References (21)

1. LORENZ E, QUAISER K. Panmyelopathie nach hepatitis epidemica. Wien Med Wochenschr 1955: 105: 19.
2. HAGLER L, PASTORE RA, BERGIN JJ. Aplastic anemia following viral hepatitis: report of two cases and literature review. Medicine 1975: 54: 139.
3. ZELDIS JB, DIENSTAG JL, GALE RP. Aplastic anemia and non-A, non-B hepatitis. Am J Med 1983: 74: 64.
4. CAMITTA BM, NATHAN DG, FORMAN EN, PARKMAN R, RAPPEPORT JM, ORELLANA TD. Post hepatic severe aplastic anemia - an indication for early bone marrow transplantation. Blood 1974: 43: 473.
5. STOCK PG, STEINER ME, FREESE DK, SHARP H, ASCHER NL. Hepatitis-associated aplastic anemia after liver transplantation. Transplantation 1987: 43: 595.
6. JOHN AG et al. Aplastic anemia complicating orthotopic liver transplantation. Hepalology 1997: 26 (4): 865.
7. TZAKIS AG et al. Aplastic anemia complicating orthotopic liver transplantation for non-A, non-B hepatitis. New Engl J Med 1988: 319: 393.
8. CATTRAL MS et al. Aplaslic anemia after liver transplantation for fulminant liver failure. Hepatology 1994: 20: 813.
9. CAMITTA BM, STORB R, THOMAS ED. Aplastic anemia. Pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med 1982: 306: 645.
10. MARSH JCW, GORDON-SMITH EC. Treatment of aplastic anemia with antilymphocyte globulin and cyclosporin. Int J Hematol 1995: 62: 133.
11. HERRMANN F, GRIFFIN JD, MEUED SG, MEYER ZUM BUSCHENFELDE KH. Establishment of an interluekin 2-dependent T cell line derived from a patient with severe aplastic anemia, which inhibits in vitro hematopoiesis. J Immunol 1986: 136: 1629.
12. WITHERSPOON RP, STORB R, SHULMAN H. Marrow transplantation in hepatitis associated aplastic anemia. Am J Hematol 1984: 17: 269.
13. BACIGALUPO A et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anemia (SAA): a report of the EBMT SAA working party. Br J Haematol 1988: 70: 177.
14. KAWAHARA K, STORG R, SANDERS J, PETERSEN FB. Successful allogenic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A, non-B hepatitis. Blood 1991: 78 (4): 1140.
15. DUGAN MJ et al. Successful allogenic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis. Bone Marrow Transpl 1993: 12: 417.
16. BACIGALUPO A et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA working party. Blood 1995: 85: 1348.
17. SHICHINO H et al. Treatment of aplastic anemia with antithymocyte globulin, cyclosporin A, methylprednisolone, danazole and recombinant human granulocyte-colony stimulating factor. Acta Paediatr Jpn 1996: 38: 644.
18. KOJIMA S, MATSUYAMA T. Stimulation of granulopoiesis by high-dose recombinant human granulocyte colony-stimulating factor in children with aplastic anemia and very severe neutropenia. Blood 1994: 83: 1474.
19. BESSHO M et al. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEPO) in severe aplastic anemia. Br J Haematol 1992: 80: 409.
20. YANG YC et al. Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3. Cell 1986: 47: 3.
21. LU L et al. Propagation of cells expressing donor phenotype (MHC class I, II and Y-choromosome) from the bone marrow of murine liver allograft recipients in response to GM-CSF in vitro. Transpl Proc 1995: 27: 191.